Article10.1007/s00280-015-2835-3
A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer
Takahiro Goji,Tetsuo Kimura,Hiroshi Miyamoto,Masanori Takehara,Kaizo Kagemoto,Yasuyuki Okada+21 more-2015-07-28-Cancer Chemotherapy and Pharmacology
8
Chat with Paper
AI Agents for this Paper
No abstract available for this paper.
Keywords
GemcitabinePancreatic cancerRadiation therapyMedicineOncologyCancerInternal medicineMaximum tolerated dose
Chat
Click to start Chat